IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Mar 14, 2024 · 10-K · 74 days after period end · 0000950170-24-031486
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$7.60M | -$7.80M | -$5.85M | -$2.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 14, 2024 · 74 d after period end
